III 

116TH CONGRESS 

1ST SESSION S. RES. 258 

Expressing support for the designation of May 2019 as ‘‘National Brain 

Tumor Awareness Month’’. 

IN THE SENATE OF THE UNITED STATES 

JUNE 20, 2019 

Mr. DAINES (for himself, Mr. MARKEY, Ms. COLLINS, Mr. VAN HOLLEN, and 

Ms. WARREN) submitted the following resolution; which was considered 

and agreed to 

RESOLUTION 

Expressing support for the designation of May 2019 as 

‘‘National Brain Tumor Awareness Month’’. 

Whereas an estimated 86,970 new cases of primary brain tumors are expected to be diagnosed in the United States 

during calendar year 2019; 

Whereas pediatric brain tumors are the leading cause of 

death from cancer in children under the age of 19; 

Whereas the average survival rate in the United States for 

all malignant brain tumor patients is only 35 percent; 

Whereas, in 2019, an estimated 16,830 people in the United 

States will die as a result of a malignant brain tumor; 

Whereas brain tumors may be malignant or benign, but can 

be life-threatening in either case; 


kjohnson on DSK79L0C42 with BILLS
2 

•SRES 258 ATS 

Whereas nearly 700,000 people in the United States are currently living with a brain tumor; 

Whereas treatment of brain tumors is complicated by the fact 

that there are more than 130 different types of brain tumors; 

Whereas the treatment and removal of brain tumors present 

significant challenges due to the uniquely complex and 

fragile nature of the brain; 

Whereas brain tumors affect the primary organ in the human 

body that controls not only cognitive ability, but the actions of every other organ and limb in the body, leading 

to brain tumors being described as a disease that affects 

the whole individual; 

Whereas brain tumor research is supported by a number of 

private, nonprofit research foundations and by Federal 

medical research institutions; 

Whereas basic research may fuel advancements and development of new treatments for brain tumors; 

Whereas obstacles to the development of new treatments for 

brain tumors remain, and there are limited strategies for 

the screening or early detection of brain tumors; 

Whereas, despite the high number of individuals diagnosed 

with a brain tumor every year and the devastating prognoses for such individuals, only 5 drugs and 1 medical 

device are approved by the Food and Drug Administration to treat brain tumors; 

Whereas the mortality rates associated with brain tumors 

have changed little during the past 30 years; 

Whereas there is a need for greater public awareness of brain 

tumors, including the difficulties associated with research 


kjohnson on DSK79L0C42 with BILLS
3 

•SRES 258 ATS 

on these tumors and the opportunities for advances in 

brain tumor research and treatment; and 

Whereas May 2019, during which brain tumor advocates nationwide unite in awareness, outreach, and advocacy activities, is an appropriate month to recognize as ‘‘National Brain Tumor Awareness Month’’: Now, therefore, 

be it 

1 Resolved, That the Senate— 

2 (1) supports the designation of May 2019 as 

3 ‘‘National Brain Tumor Awareness Month’’; 

4 (2) encourages increased public awareness of 

5 brain tumors to honor those individuals who have 

6 lost their lives to this devastating disease or cur7 rently live with a brain tumor diagnosis; 

8 (3) supports efforts to develop better treat9 ments for brain tumors that will improve the quality 

10 of life and the long-term prognoses of those individ11 uals diagnosed with a brain tumor; 

12 (4) expresses its support for those individuals 

13 who are battling brain tumors, as well as the fami14 lies, friends, and caregivers of those individuals; and 

15 (5) urges a collaborative approach to brain 

16 tumor research, which is a promising means of ad17 vancing understanding of, and treatment for, brain 

18 tumors. 

Æ 


kjohnson on DSK79L0C42 with BILLS